Company Description
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.
The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.
Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Country | United States |
| Founded | 2003 |
| IPO Date | Sep 15, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 310 |
| CEO | Leslie Trigg |
Contact Details
Address: 3052 Orchard Drive San Jose, California 95134 United States | |
| Phone | 669 231 8200 |
| Website | outsetmedical.com |
Stock Details
| Ticker Symbol | OM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $27.00 |
| CIK Code | 0001484612 |
| CUSIP Number | 690145206 |
| ISIN Number | US6901452069 |
| Employer ID | 20-0514392 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Leslie L. Trigg | President, Chief Executive Officer and Chairman |
| Renee M. Gaeta | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
| John L. Brottem J.D. | General Counsel and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 17, 2026 | 8-K | Current Report |
| Jun 5, 2026 | 8-K | Current Report |
| Jun 3, 2026 | 144 | Filing |
| May 29, 2026 | 8-K | Current Report |
| May 29, 2026 | SD | Form - SD |
| May 18, 2026 | SCHEDULE 13G/A | Filing |
| May 15, 2026 | 144 | Filing |
| May 15, 2026 | 144 | Filing |
| May 15, 2026 | 144 | Filing |
| May 15, 2026 | SCHEDULE 13G/A | Filing |